News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
388,554 Results
Type
Article (26973)
Company Profile (115)
Press Release (361466)
Section
Business (102867)
Career Advice (534)
Deals (18152)
Drug Delivery (68)
Drug Development (38686)
Employer Resources (79)
FDA (10644)
Job Trends (10068)
News (176048)
Policy (20631)
Tag
Academia (2114)
Africa (512)
Alliances (28537)
Alzheimer's disease (749)
Approvals (10614)
Arizona (81)
Artificial intelligence (52)
Asia (21199)
Australia (3761)
Bankruptcy (144)
Best Places to Work (8730)
Biosimilars (43)
Biotechnology (63)
C2C Services and Suppliers (42316)
California (915)
Canada (587)
Cancer (168)
Career advice (492)
Cell therapy (51)
China (74)
Clinical research (30378)
Collaboration (62)
Colorado (41)
Connecticut (48)
COVID-19 (2104)
Cystic fibrosis (45)
Data (115)
Diabetes (48)
Diagnostics (4576)
Drug pricing (62)
Earnings (32725)
Employer resources (68)
Europe (46905)
Events (69944)
Executive appointments (78)
FDA (10773)
Florida (149)
Funding (73)
Gene therapy (40)
Georgia (48)
GLP-1 (285)
Government (4038)
Healthcare (14817)
Hotbed/Location (262299)
Idaho (37)
Illinois (161)
Indiana (126)
Infectious disease (2122)
Inflammatory bowel disease (58)
Interviews (60)
IPO (7676)
Job creations (1431)
Job search strategy (453)
Kansas (71)
Layoffs (153)
Legal (3885)
Lung cancer (38)
Maine (54)
Manufacturing (45)
Maryland (248)
Massachusetts (809)
Medical device (9176)
Medtech (9177)
Mergers & acquisitions (10435)
Metabolic disorders (159)
Michigan (69)
Minnesota (110)
Neuroscience (823)
New Jersey (338)
New York (305)
NextGen Class of 2024 (5022)
Non-profit (3926)
North Carolina (394)
Northern California (450)
Obesity (106)
Ohio (65)
Opinion (103)
Pennsylvania (376)
People (31981)
Phase I (9681)
Phase II (11908)
Phase III (10815)
Pipeline (58)
Policy (38)
Postmarket research (1565)
Preclinical (3118)
Press Release (47)
Rare diseases (69)
Real estate (2883)
Regulatory (13329)
Research institute (1905)
Resumes & cover letters (41)
South America (688)
Southern California (362)
Startups (2282)
Texas (106)
United States (4858)
Vaccines (364)
Washington State (174)
Weight loss (85)
Date
Today (86)
Last 7 days (415)
Last 30 days (1332)
Last 365 days (23020)
2024 (15589)
2023 (24465)
2022 (33903)
2021 (37391)
2020 (37825)
2019 (33545)
2018 (25105)
2017 (17918)
2016 (19073)
2015 (21599)
2014 (16188)
2013 (12847)
2012 (13593)
2011 (14061)
2010 (12083)
388,554 Results for "seed health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Seed Health Launches VS-01, A First-of-its Kind Vaginal Microbiome Innovation to Redefine Vaginal Care
Seed Health, a microbiome science company, launched VS-01™ Vaginal Synbiotic, the first vaginal synbiotic clinically validated to rapidly establish an optimal vaginal microbiome dominated by Lactobacillus crispatus, the vagina’s most protective bacteria.
May 21, 2024
·
9 min read
Genetown
Seed Health to Present New Clinical Data on ‘DS-01® Daily Synbiotic’ for Both Antibiotic Recovery and IBS at Digestive Disease Week 2024
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week (DDW) meeting.
May 20, 2024
·
3 min read
Genetown
Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women’s Health
Heranova Lifesciences Holding Ltd. announced the successful completion of a USD 13.5 million seed and seed+ financing to develop and offer integrated Women’s Health solutions worldwide.
December 28, 2023
·
2 min read
Biotech Beach
Vesica Health to Present at the Seed Showcase, Part of Biotech Showcase, The Investor Conference for Innovators
VESICA HEALTH, INC. announced that it has been selected to participate in the Seed Showcase, part of the 2024 Biotech Showcase™.
January 2, 2024
·
5 min read
Genetown
Juniper Biomedical Secures Seed Funding to Accelerate Growth and Innovation in Pelvic Health Disorders.
Juniper Biomedical announced today that it has successfully completed an oversubscribed $2M Series Seed financing and also has been awarded $1M through the NIH Common Fund as a winner of the NIH SPARC Neuromod Prize.
April 2, 2024
·
2 min read
Drug Development
New Clinical Data Highlights Efficacy of Seed Health’s VS-01 Vaginal Synbiotic in Establishing Protective and Optimal Vaginal Microbiome
August 2, 2024
·
6 min read
Biotech Beach
āshibio Raises $40M in Seed and Series A Financing to Advance Therapies for Bone and Connective Tissue Disorders
āshibio exited stealth mode today with $40 million in seed and Series A financing.
June 20, 2024
·
6 min read
Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research
Saguaro Biosciences today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. CellCarta Biosciences, alongside strategic investments fro
June 4, 2024
·
4 min read
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Adcytherix SAS announced its incorporation and seed funding of € 30 million to develop novel antibody-drug- conjugates for the treatment of high unmet need diseases such as cancer.
June 11, 2024
·
2 min read
BioCapital
Nanochon closes $4M Series Seed Prime
Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round.
May 6, 2024
·
1 min read
1 of 38,856
Next
